BCM
CNST

BCK Capital Management’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

BCK Capital Management’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-29,800
Closed -$1.01M – 167
2021
Q2 		$1.01M Buy
+29,800
New +$759K 0.5% 42

BCK Capital Management's CNST Position: Q3 2021 in Review

BCK Capital Management sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 29,800 shares — an estimated $1.01M sold.

BCK Capital Management first reported a position in CNST in Q2 2021 and held it in 1 quarter. The position peaked at $1.01M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

  • BCK Capital Management reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • BCK Capital Management sold 29,800 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $1.01M.
  • BCK Capital Management first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2021 and held it in 1 quarter.
  • BCK Capital Management's Constellation Pharmaceuticals, Inc. position peaked at $1.01M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on BCK Capital Management's 13F filing for Q3 2021, filed 9 Nov 2021.